Clinical Trial

« Back to List

GI 162

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: December 31, 2012

Status: OPEN-IST
Research Hotline: 
803-461-3708

Details: Randomized Double-Blind, Placebo Controlled, Phase II Study of FOLFOX/ Bevacizumab with or without Met MAb as First-Line Treatment for Patients with Metastatic Colorectal Cancer

This clinical trial is being offered at the following location:Lexington Oncology

Bookmark and Share